Evaluation of the Phased Radio Frequency Ablation System (VICTORY-AF)

Sponsor: Medtronic Atrial Fibrillation Solutions Identifier: NCT01693120


VICTORY AF is an IDE, prospective global, multi-center, single arm, controlled, unblinded, investigational clinical study. The purpose of this clinical study is to evaluate the risk of procedure and/or device related strokes in subjects with persistent or long-standing persistent atrial fibrillation (AF) undergoing ablation with the Phased RF System.

Condition: Persistent Atrial Fibrillation               Phase 3

Intervention: Device: Medtronic Phased RF Ablation System
Official Title: Evaluation of Multielectrode Phased RF Technology in Persistent Atrial Fibrillation